Human menstrual blood-derived stem cells reverse sorafenib resistance in hepatocellular carcinoma cells through the hyperactivation of mitophagy.
Stem Cell Res Ther
; 14(1): 58, 2023 04 01.
Article
in En
| MEDLINE
| ID: mdl-37005657
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Liver Neoplasms
/
Antineoplastic Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
Stem Cell Res Ther
Year:
2023
Document type:
Article
Country of publication: